Bill S2820B-2011

Relates to providing pharmacists access to New York's prescription drug monitoring program resources

Relates to providing pharmacists access to New York's prescription drug monitoring program resources.

Details

Actions

  • Jun 21, 2012: COMMITTED TO RULES
  • Jun 11, 2012: ADVANCED TO THIRD READING
  • Jun 6, 2012: 2ND REPORT CAL.
  • Jun 5, 2012: 1ST REPORT CAL.1080
  • Mar 12, 2012: NOTICE OF COMMITTEE CONSIDERATION - WITHDRAWN
  • Feb 21, 2012: NOTICE OF COMMITTEE CONSIDERATION - REQUESTED
  • Jan 4, 2012: REFERRED TO HEALTH
  • Jun 15, 2011: PRINT NUMBER 2820B
  • Jun 15, 2011: AMEND (T) AND RECOMMIT TO HEALTH
  • Apr 14, 2011: PRINT NUMBER 2820A
  • Apr 14, 2011: AMEND AND RECOMMIT TO HEALTH
  • Feb 2, 2011: REFERRED TO HEALTH

Meetings

Calendars

Votes

VOTE: COMMITTEE VOTE: - Health - Jun 5, 2012
Ayes (14): Hannon, Ball, Fuschillo, Golden, Larkin, McDonald, Seward, Young, Duane, Gianaris, Montgomery, Rivera, Stewart-Cousins, Peralta
Ayes W/R (1): Adams
Excused (2): Farley, Smith

Memo

BILL NUMBER:S2820B

TITLE OF BILL: An act to amend the public health law, in relation to providing pharmacists access to New York's prescription drug monitoring program resources

PURPOSE OR GENERAL IDEA OF BILL: To allow pharmacists to request access to certain New York's Prescription Drug Monitoring Program data, in order to determine a prescription's authenticity, whether it was already filled by another pharmacy or physician, and whether the patient has engaged in "doctor shopping". New York's physicians already have this ability.

SUMMARY OF SPECIFIC PROVISIONS: Section 3371 of the Public Health Law is amended by adding a new subdivision (f) which provides pharmacists access to New York's Prescription Drug Monitoring Program.

JUSTIFICATION: This bill opens New York's Prescription Drug Monitoring Program records to pharmacists, in the same way that physicians already have access to them. Pharmacists would be able learn a patient's medical history - including doctor and pharmacy visits, prescription history, and any suspicions of drug misuse, abuse or diversion. This information could prove to be lifesaving whether for individuals seeking to abuse prescription drugs or individuals who have a complicated medical history.

Other states have opened this information to pharmacies years ago and they have done so without sacrificing patient safety, privacy or access to prescription drugs. Kentucky, a national leader in prescription drug monitoring, has studied healthcare provider satisfaction with access to such information, and found overwhelming approval. These providers agreed that recent medical history and prescription drug records provided for informed, safe and responsible decisions for their patients.

Currently, we have a limited Prescription Drug Monitoring Program in New York State. Article 33 of the Public Health Law and Part 80 of Title 10 regulations require pharmacists to electronically submit information to the New York State Department of Health (NYSDOH) from all prescriptions dispensed for controlled substances. Under this regulation, NYSDOH shall monitor the data submitted by the pharmacists to protect practitioners from drug seekers. They must also notify practitioners when analyses of official prescription data indicate that their patients are obtaining controlled substances from multiple sources, an indicator that they may be engaging in "doctor shopping." NYSDOH is still in the process of establishing this program. An obvious flaw in the current program is that pharmacists are not allowed to access the data base.

New York's laws and regulations in regard to the sharing of this information have, unfortunately, fallen behind those of other states.

This legislation gives pharmacists the ability to combat prescription drug fraud. Currently, 39 States have prescription drug monitoring laws of some sort.

This bill, if passed into law, would enable all of the parties involved in an individual patient's healthcare decisions to have information necessary to make the right prescription drug choices. It is also part of a two bill package to strengthen New York State's Prescription Monitoring Program.

PRIOR LEGISLATIVE HISTORY: S.7684 - Died in Senate Health.

FISCAL IMPLICATIONS: Minimal administrative costs.

EFFECTIVE DATE: This act shall take effect immediately.


Text

STATE OF NEW YORK ________________________________________________________________________ 2820--B 2011-2012 Regular Sessions IN SENATE February 2, 2011 ___________
Introduced by Sen. LANZA -- read twice and ordered printed, and when printed to be committed to the Committee on Health -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to providing pharma- cists access to New York's prescription drug monitoring program resources THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Paragraphs (d) and (e) of subdivision 1 of section 3371 of the public health law, as amended by chapter 178 of the laws of 2010, are amended and a new paragraph (f) is added to read as follows: (d) to a central registry established pursuant to this article; [and] (e) to a practitioner to inform him or her that a patient may be under treatment with a controlled substance by another practitioner; OR (F) TO A PHARMACIST TO INFORM THE PHARMACIST THAT A PERSON WHO PRESENTS OR HAS PRESENTED A PRESCRIPTION FOR ONE OR MORE CONTROLLED SUBSTANCES AT THE PHARMACY MAY HAVE ALSO OBTAINED ONE OR MORE CONTROLLED SUBSTANCES FROM ANOTHER PHARMACY, WHERE THE CIRCUMSTANCES INDICATE A POSSIBILITY OF DRUG ABUSE OR DIVERSION, POTENTIAL HARM TO THE PERSON, OR SIMILAR GROUNDS. S 2. This act shall take effect immediately.

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Discuss!

blog comments powered by Disqus